Valemetostat for Relapsed or Refractory B-Cell Lymphomas: Primary Results from a Phase 1 Trial-MedSci.cn - 梅斯（MedSci）

Valemetostat for Relapsed or Refractory B-Cell Lymphomas: Primary Results from a Phase 1 Trial

Izutsu, K; Ishitsuka, K; Maruyama, D; Tsukasaki, K; Kusumoto, S; Kakurai, Y; Yamauchi, H; Inoue, A; Tachibana, M; Tsutsumi, S; Tobinai, K

BLOOD, 2023; 142 ():

科室
- - 订阅+
  - 更多科室
工具
服务